Get In Touch

Who We Are

NOVEL is an Award Winning Team of Experienced Professionals with Expertise in Health Economics and Outcomes Research, Market Access, Pricing, Payer Strategy, Publications, GVD and Reimbursement.

Our Team is Comprised of Strategists, ex-Payers, HEOR Experts and Market Access Professionals.

Our Experience

Our Team has Experience Leading Projects for Majority of Top 50 Pharmaceutical and Medical Device Companies. Novel Health has led US & Global Projects on Blockbuster and Niche Medical Products.

Our Team is a Preferred Consulting Partner of Top Pharmaceutical and Device Manufacturers.

Contacts

NOVEL has a Large Network of Internal and External Stakeholders, including KOLs, Payers and Patient Advocacy Groups.


Strategy Overview on Breakthrough Therapy Designations (Nature Biotech, April 2014)

NOVEL just published a comprehensive overview on all Breakthrough Therapy Designated products, covering their clinical, HEOR, comparative effectiveness and market access.

Read More

NOVEL Won Two Platinum and Bronze Medal Awards at AMCP

NOVEL's team won two Platinum and Bronze Medal Awards for Presentations at AMCP Nexus Educational Conference in Boston

Read More

Nineteen Presentations at ISPOR 2013 New Orleans

NOVEL's team presented nineteen studies on HEOR and market access trends at the 18th Annual International ISPOR meeting in New Orleans.

Read More

Podium & Poster Presentations at HTAi 2013 Seoul, Korea

At the Health Technology Assessment HTAi Annual 2013 Meeting in Seoul, Korea, NOVEL's team was selected for podium and poster presentations.

Read More

Annual Strategy Perspective in Nature Biotechnology

Our annual strategy series has been cited and quoted more than two hundred times. JUST PUBLISHED latest article in January 2014 issue.

Read More

Market Access & Reimbursement Strategy Seminar in Copenhagen

NOVEL's team and leading healthcare stakeholders hosted a one-day workshop on Market Access & Reimbursement Strategy in Copenhagen (Ministry of Foreign Affairs, Denmark).

Read More